All living tissues, when kept under stress conditions, will generate substances that make it possible for the tissue to survive.
Vladimir Filatov, 1875 – 1956
1943
Farmaceutici DAMOR was founded in 1943 in Italy as a Galenic laboratory.
1943
Farmaceutici DAMOR was founded in 1943 in Italy as a Galenic laboratory.
1946
In 1946, we discovered the clinical properties of the Triticum Vulgare Extract. This determined the Galenic lab to be converted into a pharmaceutical company.
1946
The discovery of the Triticum Vulgare Extract was inspired by the theories of the scientist Vladimir Filatov, who identified and defined the ‘’Biostimulins’’
2017
In 2017 we developed and patented an innovative extraction process from the seeds of Triticum Vulgare. This process represents the pillar of the historical technical knowledge of the company and the specialization in natural bio-pharma products.
2017
In 2017 we developed and patented an innovative extraction process from the seeds of Triticum Vulgare. This process represents the pillar of the historical technical knowledge of the company and the specialization in natural bio-pharma products.
today
We aim to be a trusted leader in discovering how the Triticum Vulgare Extract can ameliorate the quality of life and to allow to the largest portion of the eligible population to have access to our products
today
We aim to be a trusted leader in discovering how the Triticum Vulgare Extract can ameliorate the quality of life and to allow to the largest portion of the eligible population to have access to our products
Research &
Development
Our R&D lab is specialized in the study of the bio-pharmaceutical properties of the Triticum Vulgare extract. We have a specific know-how on the Triticum Vulgare extract supported by many publications on International Scientific Journals. We have several collaborations with universities and Research Institutes.
Manufacturing
We produce and manufacture in Italy. Our manufacturing is sited in Naples with a 16,000 square meters size. We guarantee the best manufacturing quality standards. Each product is manufactured following Good Manufacturing Practices standard (GMP), and both the production and the working procedures are periodically controlled by the Italian Healthcare System (AIFA). Besides the GMP standard, the Company is aligned with ISO 9001, ISO 13485 standards for medical devices and ISO 14001, which regulates the impact on the environment.
focuson
Triticum Vulgare Extract
Pharmaceuticals Damor completely controls the manufacturing process of products containing the particular Triticum Vulgare Water Extract, from the Active Principle to the Finished Product with a complete LQC state of the art.
The active components of the particular Watery Extract of Triticum Vulgare are obtained through a standardized process patented all over the world.
